StockData
Azitra, Inc. logo

Azitra, Inc. (AZTR) stock

AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.57−0.04 (-6.20%)

Close on Nov 18, 2026Market cap $34.56MP/E –Yield –

Azitra operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Azitra's operating income for the twelve months ending Jun 30, 2026 was -$12.35M. For fiscal 2025 it was -$10.97M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.97M–
FY2024Dec 31, 2024-$10.99M–
FY2023Dec 31, 2023-$7.45M–
FY2022Dec 31, 2022-$9.45M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.42M–
Q1 FY2026Mar 31, 2026-$3.93M–
Q4 FY2025Dec 31, 2025-$2.23M–
Q3 FY2025Sep 30, 2025-$2.77M–
Q2 FY2025Jun 30, 2025-$2.87M–
Q1 FY2025Mar 31, 2025-$3.10M–
Q4 FY2024Dec 31, 2024-$2.43M–
Q3 FY2024Sep 30, 2024-$2.93M–
Q2 FY2024Jun 30, 2024-$2.66M–
Q1 FY2024Mar 31, 2024-$2.96M–
Q4 FY2023Dec 31, 2023-$2.47M–
Q3 FY2023Sep 30, 2023-$1.99M–
Q2 FY2023Jun 30, 2023-$1.43M–
Q1 FY2023Mar 31, 2023-$1.56M–
Q4 FY2022Dec 31, 2022-$2.70M–
Q3 FY2022Sep 30, 2022-$2.37M–
Q2 FY2022Jun 30, 2022-$2.09M–

More Azitra figures

See a number that looks wrong?